Company Overview - Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on oncology, developing proprietary antibody-based therapeutics for multiple human diseases [2] - The company was founded in 2014 and is headquartered in Boston, Massachusetts [2] Scientific Focus - The scientific focus of Compass Therapeutics is on the relationship between angiogenesis, the immune system, and tumor growth [2] - The pipeline includes novel product candidates targeting critical biological pathways for effective antitumor responses, such as modulation of microvasculature and induction of immune responses [2] Product Development Strategy - Compass plans to advance its product candidates through clinical development as standalone therapies and in combination with proprietary pipeline antibodies [2] - The development is based on supportive clinical and nonclinical data [2] Upcoming Events - Compass Therapeutics will present at the Wedbush PacGrow Healthcare Conference in New York City on August 13, 2024, at 11 AM ET [1]
Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference